Bixiye
QP8-19 Addition of Drugs to the Oral Tetracycline Derivatives Prior Authorization Program
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2791 - 2800 ee natiijooyinka 3289
Bixiye
QP12-19 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Immune Globulins
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP15-19 Online Medical Policy Surveys for Authorizations
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP9-19 Addition of Drugs to existing Prior Authorization with Quantity Limit Programs
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP13-19 Medicare Vaccine Coverage
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP11-19 April is STI/STD Awareness Month
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP10-19 Pharmacy Benefit Exclusion for Dymista, Duexis, Qbrexza, Vimovo, and Yosprala
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
QP14-19 Minnesota Health Care Programs (MHCP) Claims Pending
Taariikhda uu dhaqangalayo Barnaamijka: 13, Feb 2019
Bixiye
P21-19 Reminder Regarding Minnesota Health Care Programs and Minnesota Senior Health Options Pre-certification Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 31, 2019
Bixiye
P22-19 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2019